Skip to content

Clinical trials

Withdrawn Immunoblastic Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Status: Withdrawn Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20073
20081
20141
20151
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
University of Medicine and Dentistry of New Jersey2
Eastern Cooperative Oncology Group1
Eric Jacobsen, MD1
Fred Hutchinson Cancer Center1
Northwestern University1
Rutgers, The State University of New Jersey1
University of Miami1
University of Texas Southwestern Medical Center1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy12
Lymphoma, Large-Cell, Anaplastic10
Lymphoma, T-Cell, Cutaneous10
Mycosis Fungoides10
Sezary Syndrome10
Burkitt Lymphoma9
Hodgkin Disease9
Intraocular Lymphoma9
Leukemia, Lymphocytic, Chronic, B-Cell9
Lymphoma, B-Cell, Marginal Zone9

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.